samedan logo
 
 
spacer
home > epc > Spring 2010
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2010

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

   
Text
PDF
bullet
Marketplace & Business
With the world's biggest population and one of its fastest growing pharmaceutical markets, the benefits of conducting clinical trials in China are overwhelming. Albert Liou at PAREXEL International explores the Chinese R&D landscape in more detail.
 
view
download pdf
Gail Kniveton at i3 Pharma Resourcing examines the critical but often overlooked area of staff training, arguing that in times of economic difficulty, it is more important than ever for companies to choose the right training strategy and exploit it to the full.  
view
download pdf
Management teams seeking improvements to their bottom line and operational performance are showing renewed interest in Lean and Six Sigma ways of thinking. Julian Mosquera at LCP Consulting takes a fresh look at the most effective means of adopting these methodologies.  
view
download pdf
bullet
Legal & Regulatory
Christopher Beckham and Bruce C Haas at Fitzpatrick, Cella, Harper & Scinto discuss why intellectual property procurement and enforcement have become greater priorities for the pharma industry in the context of the global economic downturn.  
view
download pdf
bullet
Clinical Development
Paper-based methods of collecting patient data are increasingly being cast aside in favour of electronic solutions. Mark Taggart and patrick Hughes at Exco InTouch look at how the mobile phone revolution can help to increase efficiency and reliability in the patient reporting process  
view
download pdf
Adrian Iancu at Global Clinical Trials reviews the impressive development of the clinical research landscape in Romania since its accession to the EU in 2007, looking at the country's advantages in terms of demographics and research experience.  
view
download pdf
Negotiating financial agreements between sponsors and CROs can be fraught with difficulty. Anna Ravdel at Synergy Research Grouo examines the change order process in detail, outlining the key choices to consider.  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
Lee Ann Applegate at the University Hospital of Lausanne (CHUV) and Dominique P Pioletti at the Swiss Federal Institute of Technology Lausanne (EPFL) advocate an interdisciplinary approach to developing new therapies, which can help to assure patient safety.  
view
download pdf
Although the practice of medicine has traditionally focused on population analyses, it is now widely acknowledged that techniques of personalised medicine can offer significant benefits to patients; David S Lester of ITHW reviews developments in the field.  
view
download pdf
Kathryn Chapman and Vicky Robinson at the National Centre for Replacement, Refinement and Reduction of Animals in Research present the need to change accepted testing methods in light of the growing redundancy of animal research in certain areas.  
view
download pdf
bullet
Data Management & IT Solutions
A bottle of wine has more in common with standards for clinical data than you might think, explain Dave Iberson-Hurst and AJ de Montjoie at CDISC, with insight into the past, present and future of CDISC standards.  
view
download pdf
Andrew MacGarvey at Quanticate discusses the shift away from 'treating sickness' and towards 'managing wellness' in the healthcare industry, and considers the role that the collection, cleaning and reporting of clinical data has to play in this progression.  
view
download pdf
bullet
LABS & Logistics
Amy Furlong at ERT returns to the theme of centralised ECG data collection, looking at the advantage of this paradigm when compared to the traditional decentralisd model, which include greater consistency and cost savings.  
view
download pdf
Everyone involved in the cold chain is aware of the need to keep things cool, but a recent report in the UK has highlighted the dangers of temperatures falling too low; Ana Carmona-Rodriguez at Gemini Data Loggers (UK) Ltd and Dawn Brown, freelance Consultant, show how data logging can help meet regulatory requirements.  
view
download pdf
Jean Bédard from Alternatives Technologie Pharma Inc discusses how automatic monitoring technology can make the business of avoiding temperature extremes in the pharmaceutical cool chain simpler and more transparent.  
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

2019 Pharmapack Awards

Pharmapack Europe have announced entries for the 2019 Pharmapack Awards are now open across both the ‘Exhibitor Innovation’ and ‘Health Products’ categories with a closing date of 30th November 2018. The Health Products category will include two winners with one for Patient-Centric Design – which is launched in partnership with HCPC Europe (Healthcare Compliance Packaging Council of Europe) – and a second introduced alongside Adelphe for Eco-design in health packaging and drug delivery devices. Pharmapack Europe have also announced that they’re accepting applications for the start-up hub which provides young start-up companies servicing the pharma industry with the benefit of valuable networking and learning opportunities at half the price of a regular stand.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement